|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Accounts Receivable, Net | ||||||||||||||||||||
| Advances to Operators | ||||||||||||||||||||
| Prepaid Expenses and Other | ||||||||||||||||||||
| Advances, Prepaid Expenses, and Other | ||||||||||||||||||||
| Derivative Instruments | ||||||||||||||||||||
| Income Tax Receivable | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and Equipment: | ||||||||||||||||||||
| Oil and Natural Gas Properties, Full Cost Method of Accounting | ||||||||||||||||||||
| Proved | ||||||||||||||||||||
| Unproved | ||||||||||||||||||||
| Other Property and Equipment | ||||||||||||||||||||
| Total Property and Equipment | ||||||||||||||||||||
| Less – Accumulated Depreciation, Depletion and Impairment | ||||||||||||||||||||
| Less – Accumulated Depletion and Impairment | ||||||||||||||||||||
| Total Oil and Natural Gas Properties, Net | ||||||||||||||||||||
| Other Property and Equipment, Net | ||||||||||||||||||||
| Total Property and Equipment, Net | ||||||||||||||||||||
| Derivative Instruments | ||||||||||||||||||||
| Acquisition Deposit | ||||||||||||||||||||
| Deferred Income Taxes | ||||||||||||||||||||
| Other Noncurrent Assets, Net | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts Payable | ||||||||||||||||||||
| Accrued Liabilities and Other | ||||||||||||||||||||
| Accrued Interest | ||||||||||||||||||||
| Income Tax Payable | ||||||||||||||||||||
| Derivative Instruments | ||||||||||||||||||||
| Contingent Consideration | ||||||||||||||||||||
| Other Current Liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-term Debt, Net | ||||||||||||||||||||
| Deferred Tax Liability | ||||||||||||||||||||
| Derivative Instruments | ||||||||||||||||||||
| Contingent Consideration | ||||||||||||||||||||
| Asset Retirement Obligations | ||||||||||||||||||||
| Other Noncurrent Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Common Stock, Par Value $0.001; 270,000,000 Shares Authorized; 106,549,128 Shares Outstanding at 6/30/2026 97,265,559 Shares Outstanding at 12/31/2025 | ||||||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
